United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63629-3209_82084f4e-00d0-c298-c13a-88a6c0860b02
- Product NDC
- 63629-3209
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20020703
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 40 TABLET in 1 BOTTLE (63629-3209-0) · 63629-3209-0
- 30 TABLET in 1 BOTTLE (63629-3209-1) · 63629-3209-1
- 60 TABLET in 1 BOTTLE (63629-3209-2) · 63629-3209-2
- 90 TABLET in 1 BOTTLE (63629-3209-3) · 63629-3209-3
- 120 TABLET in 1 BOTTLE (63629-3209-4) · 63629-3209-4
- 100 TABLET in 1 BOTTLE (63629-3209-5) · 63629-3209-5
- 84 TABLET in 1 BOTTLE (63629-3209-6) · 63629-3209-6
- 28 TABLET in 1 BOTTLE (63629-3209-7) · 63629-3209-7
- 21 TABLET in 1 BOTTLE (63629-3209-8) · 63629-3209-8
- 160 TABLET in 1 BOTTLE (63629-3209-9) · 63629-3209-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →